genprowebdirectory
GEN Edge
News
Insights
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Supplement
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
DNA
X and Y: Synthorx Expands the Genetic Code to Create Optimized…
Cancer
Set Phase Separation to Stun
Gene Therapy
A New Vision for Gene Therapy
OMICs
Can Encodia Become the Illumina of Proteomics?
Alzheimers
Cognition Thinks It Has an Alzheimer’s Blockbuster
News
Bioprocessing
Industry Expert Seeks New Biomanufacturing Plant in the North of England
Bioprocessing
Cecil College Launches Bioprocessing Program
Coronavirus
Moderna Seeking Emergency Use Authorization for COVID-19 Vaccine
Coronavirus
Recurrent Mutations in SARS-CoV-2 Doesn’t Increase Transmissibility
Cancer
Potential Protein Protection for Kidneys from Cancer Therapies Discovered
Insights
All
Trends for 2020
Drug Discovery
Multi-Attribute Methods Supporting Quality Assessments of Therapeutic Proteins
Bioprocessing
COVID Driving Biopharma to Embrace Digital Tech Faster
Bioprocessing
Boosting Capabilities in Gene and Cell Therapy Bioprocessing
Bioprocessing
Bioprocessing’s Potential Impact on Patients
A-Lists
A-Lists
Top 50 NIH-Funded Institutions of 2020
July 2020 Vol. 40 No. 7
Top 10 Earners among Women Biopharma Executives
June 2020 Vol. 40 No. 6
In Praise of Lesser-Sung Life Sciences Clusters
Coronavirus
Blinking Red: 25 Missed Pandemic Warning Signs
Coronavirus
Vanquishing the Virus: 160+ COVID-19 Drug and Vaccine Candidates in Development
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Bioprocessing
Industry Expert Seeks New Biomanufacturing Plant in the North of England
Bioprocessing
Cecil College Launches Bioprocessing Program
Coronavirus
Moderna Seeking Emergency Use Authorization for COVID-19 Vaccine
Cancer
Potential Protein Protection for Kidneys from Cancer Therapies Discovered
Magazine
All
Supplement
November 2020 Vol. 40 No. 11
With Synthetic Biology Nature Is All Business
Biobanking
Biobanks Are Becoming Data Banks in the Era of Personalized Medicine
Biobanking
Cryopreservation to Improve Cell Manufacturing and Biobanking
Biobanking
Enabling Scientific Discovery and Healthcare with Biobanks
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Companies
Amgen
Amgen
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Amgen
Amgen Expands China Presence, Cancer R&D with $2.7B BeiGene Collaboration
Amgen
Amgen Eyes Inflammatory Disease Expansion with Planned $13.4B Purchase of Celgene’s Otezla
Amgen
Amgen Offers $167M for Cancer Collaboration Partner Nuevolution
Amgen
Amgen, Entera to Partner on Oral Drugs for Inflammatory Disease, Other “Serious” Illnesses
Amgen
Amgen Selects Second Cancer Target in 2-Year-Old Collaboration with Nuevolution
Amgen
Amgen, MD Anderson Launch Two Cancer Collaborations
Amgen
Amgen, Novartis Set to Launch Migraine Drug Aimovig Next Week after...
Amgen
Federal Circuit Favors Novartis’ Sandoz over Amgen in Biosimilar “Patent Dance”...
Amgen
Amgen, Novartis Expand Alzheimer’s Collaboration with New Trial
Amgen
Amgen, CytomX Launch Up-to-$1.465B+ Cancer Immunotherapy Collaboration
Amgen
Amgen Delaying U.S. Launch of Humira Biosimilar in Settlement with AbbVie
Amgen
After FDA Approval, Amgen–Allergan Cancer Biosimilar Mvasi Faces Launch, Pricing Challenges
Amgen
FDA to Review BLA for Amgen-Novartis Migraine Prevention Treatment
Amgen
Amgen Licenses Ligand’s Captisol Technology for AML Candidate AMG 330
Amgen
FDA Rejects Amgen-UCB Osteoporosis Candidate Evenity
Load more
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
